Motor dysfunction in elderly patients with chronic musculoskeletal system diseases (locomotive syndrome)
Locomotive syndrome (LS) is defined as an unsatisfactory condition in patients after the age of 60 years, in which they require or may require physical assistance soon due to deterioration in the functional state of the musculoskeletal system, including pathology of bone tissue, joints, muscles, and...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2021-04-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/1552 |
| _version_ | 1797876345194151936 |
|---|---|
| author | M. V. Putilina N. V. Teplova O. A. Gromova I. Yu. Torshin M. Yu. Maksimova Yu. S. Prokofieva |
| author_facet | M. V. Putilina N. V. Teplova O. A. Gromova I. Yu. Torshin M. Yu. Maksimova Yu. S. Prokofieva |
| author_sort | M. V. Putilina |
| collection | DOAJ |
| description | Locomotive syndrome (LS) is defined as an unsatisfactory condition in patients after the age of 60 years, in which they require or may require physical assistance soon due to deterioration in the functional state of the musculoskeletal system, including pathology of bone tissue, joints, muscles, and the nervous system. The problem of LS treatment in elderly patients is relevant for all countries over the world. The presence of chronic somatic and neurological diseases in most older adults can complicate LS assessment and reduce treatment effectiveness. The patient's functional status and ability to continue activities of daily living should be assessed at the first visit to determine the degree of independence, the level of need for caregivers, and the overall quality of life. LS treatment should be permanent and include kinesiotherapy, professional psychological support, and complex drug therapy. The use of vital micronutrients, which include highly purified forms of chondroitin sulfate and glucosamine sulfate, which have a wide range of anti-inflammatory and regenerative effects, can provide the safety of long-term drug therapy. |
| first_indexed | 2024-04-10T02:00:41Z |
| format | Article |
| id | doaj.art-3c2439cb86f74c0c81df9c737bd5bdd7 |
| institution | Directory Open Access Journal |
| issn | 2074-2711 2310-1342 |
| language | Russian |
| last_indexed | 2024-04-10T02:00:41Z |
| publishDate | 2021-04-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Неврология, нейропсихиатрия, психосоматика |
| spelling | doaj.art-3c2439cb86f74c0c81df9c737bd5bdd72023-03-13T08:42:21ZrusIMA-PRESS LLCНеврология, нейропсихиатрия, психосоматика2074-27112310-13422021-04-0113213013610.14412/2074-2711-2021-2-130-1361123Motor dysfunction in elderly patients with chronic musculoskeletal system diseases (locomotive syndrome)M. V. Putilina0N. V. Teplova1O. A. Gromova2I. Yu. Torshin3M. Yu. Maksimova4Yu. S. Prokofieva5N.I. Pirogov Russian National Research Medical University, Ministry of Health of RussiaN.I. Pirogov Russian National Research Medical University, Ministry of Health of RussiaFederal Research Center «Informatics and Management», Russian Academy of Sciences; Center for Big Data Storage and Analysis, National Center for Digital Economy, M.V. Lomonosov Moscow State UniversityFederal Research Center «Informatics and Management», Russian Academy of Sciences; Center for Big Data Storage and Analysis, National Center for Digital Economy, M.V. Lomonosov Moscow State UniversityResearch Center of NeurologyA.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of RussiaLocomotive syndrome (LS) is defined as an unsatisfactory condition in patients after the age of 60 years, in which they require or may require physical assistance soon due to deterioration in the functional state of the musculoskeletal system, including pathology of bone tissue, joints, muscles, and the nervous system. The problem of LS treatment in elderly patients is relevant for all countries over the world. The presence of chronic somatic and neurological diseases in most older adults can complicate LS assessment and reduce treatment effectiveness. The patient's functional status and ability to continue activities of daily living should be assessed at the first visit to determine the degree of independence, the level of need for caregivers, and the overall quality of life. LS treatment should be permanent and include kinesiotherapy, professional psychological support, and complex drug therapy. The use of vital micronutrients, which include highly purified forms of chondroitin sulfate and glucosamine sulfate, which have a wide range of anti-inflammatory and regenerative effects, can provide the safety of long-term drug therapy.https://nnp.ima-press.net/nnp/article/view/1552locomotive syndromesenile astheniasarcopeniaosteoarthritisfallsimbalancechondroitin sulfate |
| spellingShingle | M. V. Putilina N. V. Teplova O. A. Gromova I. Yu. Torshin M. Yu. Maksimova Yu. S. Prokofieva Motor dysfunction in elderly patients with chronic musculoskeletal system diseases (locomotive syndrome) Неврология, нейропсихиатрия, психосоматика locomotive syndrome senile asthenia sarcopenia osteoarthritis falls imbalance chondroitin sulfate |
| title | Motor dysfunction in elderly patients with chronic musculoskeletal system diseases (locomotive syndrome) |
| title_full | Motor dysfunction in elderly patients with chronic musculoskeletal system diseases (locomotive syndrome) |
| title_fullStr | Motor dysfunction in elderly patients with chronic musculoskeletal system diseases (locomotive syndrome) |
| title_full_unstemmed | Motor dysfunction in elderly patients with chronic musculoskeletal system diseases (locomotive syndrome) |
| title_short | Motor dysfunction in elderly patients with chronic musculoskeletal system diseases (locomotive syndrome) |
| title_sort | motor dysfunction in elderly patients with chronic musculoskeletal system diseases locomotive syndrome |
| topic | locomotive syndrome senile asthenia sarcopenia osteoarthritis falls imbalance chondroitin sulfate |
| url | https://nnp.ima-press.net/nnp/article/view/1552 |
| work_keys_str_mv | AT mvputilina motordysfunctioninelderlypatientswithchronicmusculoskeletalsystemdiseaseslocomotivesyndrome AT nvteplova motordysfunctioninelderlypatientswithchronicmusculoskeletalsystemdiseaseslocomotivesyndrome AT oagromova motordysfunctioninelderlypatientswithchronicmusculoskeletalsystemdiseaseslocomotivesyndrome AT iyutorshin motordysfunctioninelderlypatientswithchronicmusculoskeletalsystemdiseaseslocomotivesyndrome AT myumaksimova motordysfunctioninelderlypatientswithchronicmusculoskeletalsystemdiseaseslocomotivesyndrome AT yusprokofieva motordysfunctioninelderlypatientswithchronicmusculoskeletalsystemdiseaseslocomotivesyndrome |